Press Room

Article / Jun 01, 2007

Enforcing GMP compliance for APIs in EU medicines

Pharmaceutical Technology Europe, June 2007

The legal basis for APIs for the EU market to be manufactured under GMP — a requirement already in place in the US since the 1970s — was created through a directive adopted in March 2004. Health authorities in the EU are now gradually increasing their enforcement efforts and are training their inspectors to check for GMP compliance of APIs used in medicines marketed in the EU. In November 2006, a majority in the EU Parliament voted in favour of an important ‘Written Declaration’ that proposes that only GMP-certified APIs will be allowed in EU medicines.

The Active Pharmaceutical Ingredients Committee (APIC) — a sector...

Also in the Press Room

News / May 11, 2017

Bioconnect Seminar at the Hovione Cork Site

The Hovione site welcomed close to 50 people from the Irish Pharma, Biotech and University sectors for a combined seminar with Bioconnect Ireland on the theme of Tech Transfer in the pharmaceutical industry.